Common Medicines For Kidney Cancer Damage The Protein Structure. Part 2 of 3

Common Medicines For Kidney Cancer Damage The Protein Structure – Part 2 of 3

Bevacizumab belongs to a class of drugs known as angiogenesis inhibitors, which lessen the formation of new blood vessels around tumors. Avastin (bevacizumab), manufactured by Genentech, was recently approved to treat the most common type of kidney cancer.

american

In 2009, the US Food and Drug Administration approved the use of Avastin in concert with interferon-alfa, an immunotherapy drug, to present renal cell carcinoma that has spread to other organs in the body. A phase III trial found that the dope combination increased progression-free survival time by approximately five months, compared to use of interferon-alfa alone. The study wasn’t able to determine whether the dual treatment extended patients’ lives, according to the American Cancer Society.

Parts: 1 2 3

Advertisements

2 thoughts on “Common Medicines For Kidney Cancer Damage The Protein Structure. Part 2 of 3

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s